Regarding the last part of your post, I don’t think it
Regarding the last part of your post, I don’t think it was Dr Jay’s communications at all that resulted in “The Letter”: The previous blunders, amateur approaches and incomplete/mis-formatted BLA filings as well as blatantly ignoring the FDA warnings contributed. The bogus press releases and Proactive videos made anyone with knowledge of the rules that are expected in PhRMA/Biotech and regulatory affairs, cringe as they were so out of line with what can legally (jmo - not legal advice) be said from a company either developing a drug or one that has already been approved.
It is a very serious offense to misrepresent a drug before it has passed certain hurdles established by the FDA. That is not a slight whatsoever on the efficacy of LL and what we all were witnessing across multiple disease states. You just can’t use words like (these are my words)- Amazing, Better, Beautiful…; this is a standard (and bare minimum) understanding in the Industry and NP didn’t get that. The Amerex debacle made things terrible for LL to get approved.
Then there was a pitchforks and torches period where mob mentality ruled and cydy enthusiasts were pressing to write the FDA and demand approval, without LL having passed the proper regulatory hurdles. The FDA took this to mean thar NP ‘s premature and out of bounds languaging was getting through to the “Lay” (their word from the letter) and they have to take that seriously because it, again, Hadn’t gone through the proper regulatory process and cross the proper hurdles to obtain approval.
What is the letter harsh? Absolutely. Could it have been handled a different way? Absolutely. I disagree with many of the characterizations of LL in that letter, but the letter was not caused by Dr. Jay. It was years in the making from the fumblers of Amerex Along with the points that I have noted above.
*I again implore folks to let SA handle things.
Having said that I am 100% confident that Dr. Jay is the right man for the job and I say this because of the way he speaks. Like it or not, he has to be respectful of the FDA and he has to speak and write in a language that Does not trigger them. They are bureaucrats and they work under a system. That system has certain steps that must occur and If you step out of line, they will push back. Dr. Jay understands this and his experience in clinical trials and regulatory affairs of drug approvals are a godsend to our cause. His passion for improving, the lives of patience is a bonus to say the least.
20
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Understanding Anchorage's Real Estate Climate In the bustling world of Anchorage real estate, it's not what you hear nationally that counts—it's about reading the nuances of your own backyard. That’s the principal mantra disseminated by Real Estate Expert Gary Cox, affectionately known as the 'King', in his latest discourse with HelloNation. A pertinent perspective...
Continue Reading
Third Quarter Upsurge: A Strategic Move Grabbing investors' attention, Integra Resources Corp., listed as NYSE: ITRG, delivered a juicy Q3 2026 report, marking a period of production strength and financial stability. This wasn't some fluke. The company's operation at Florida Canyon Mine stood out, logging in formidable numbers. Operating cash flow and revenue inched...
Continue Reading
Connecting the Dots in Smart Homes You ever find yourself fiddling around with three remotes to dim the lights and crank up the thermostat? I reckon you're not alone. Well, Tuya Smart just threw a curveball into the mix. They've teamed up with Meta's Muse to create Tuya Cloud Devices, an open-source Skill that's designed to let folks control their smart home tech with...
Continue Reading
Allegations at the Heart of the Matter When school administrators turn a blind eye to student safety, there's bound to be fallout. Jaclyn Schwieger, a former coach at Latin School of Chicago, has hit back with a federal lawsuit. She claims her concerns about questionable behavior by male volleyball coaches were met with reprisal rather than resolution. Now she's taking...
Continue Reading
The Road to Green: LiuGong’s Ambitious Vision In a world where more heads are turning towards sustainability, LiuGong stepped up and showcased its green aspirations with flare at the 2026 Global Dealer Conference held from November 10 to 12 in Liuzhou, China. Over 2,000 attendees, ranging from dealers to customers, were in attendance to witness what seemed to be both a...
Continue Reading
UMG Steps into the Spotlight at Morgan Stanley Event Music, money, and technology—it's a compelling trio. Universal Music Group (EURONEXT: UMG) is sending its heavyweights, Matt Ellis and Michael Nash, to the Morgan Stanley European Technology, Media & Telecom Conference on November 18, 2026. This isn't just any run-of-the-mill industry hobnob. We're talking about the...
Continue Reading
Aristocrat's Upcoming Change at the Helm Shuffling the deck at the top can make or break a ship. Aristocrat is swapping its captain as Trevor Croker steps down, and they're betting Dafne Guisard's got the wind in her sails to ride the next wave. This ain't your average CEO transition, either—it's got a whole year of easing into the reins. The Decision to Appoint Guisard...
Continue Reading
Lightwave Logic Faces Legal Hurdles There's trouble brewing for Lightwave Logic, Inc. (NASDAQ: LWLG) after its decision to push back volume production to 2028 stirred the pot. Shares took a nosedive, opening down by about 15% at $3.73, after the company revealed their foundry process and customer qualifications were dragging at a snail's pace. And as you might expect,...
Continue Reading
If you've ever wondered about the intersection of military discipline and entrepreneurial spirit, LINE-X is handing veterans the keys, quite literally. With a nod to leathernecks and GIs, they're slashing their franchise fee by 25% for U.S. veterans aiming to trade sergeants' stripes for business clout. Franchising for Veterans: A Tailored Offer So, the word on the street...
Continue Reading
Understanding Humanity's Need for Space Exploration Forget the fancy rockets and advanced gizmos for a minute. According to Daniel Fox, Co-Founder of FUTURE of SPACE, space exploration isn't suffering from a lack of tech; it's missing a compelling narrative. As we gear up for SpaceX's Starship launch on November 13, Fox insists that understanding why we venture into space...
Continue Reading
Top 5 Most Recently Viewed Articles
Exciting Times for Ledger Markets Global Ledger Markets Global, a renowned name in the cryptocurrency trading arena, is thrilled to announce an impressive surge in user registration driven by recent platform enhancements. These improvements are carefully crafted to simplify the cryptocurrency trading experience and increase efficiency. This milestone has captured the...
Continue Reading
Amen Properties Reports Revenue Growth in Q2 Amen Properties, Inc. (Pink Sheets: AMEN) has released its financial results for the last quarter, showing a positive trend in its financial health. The company’s revenue rose to $1.3 million, up from $1.2 million during the same period last year. However, the net income this quarter was reported at $574 thousand, which is a...
Continue Reading
Artelo Biosciences Overview Artelo Biosciences, Inc. (NASDAQ: ARTL) is actively advancing research in cannabinoid therapy, with its latest focus on treating patients experiencing cancer-associated anorexia-cachexia syndrome (CACS). This condition is prevalent among cancer patients and leads to significant challenges, such as decreased appetite, weight loss, and muscle...
Continue Reading
Recent Trends in Cryptocurrency Markets As the cryptocurrency landscape continues to evolve, Bitcoin recently broke through the $98,000 mark, marking a significant milestone for its investors. This achievement has sparked discussions among market analysts about potential future movements of Bitcoin and other leading cryptocurrencies. Market Behavior Overview On the same...
Continue Reading
Revolutionary Hair Restoration Solution for Women Hairstetics is proud to announce the expansion of its groundbreaking medical procedure aimed at combating female hair loss, a prevalent issue impacting nearly half of women by the age of 80. This innovation utilizes minimally invasive techniques to implant synthetic hair fibers, providing an effective FemTech solution that...
Continue Reading